Early safety check for drug aimed at preventing preeclampsia
NCT ID NCT06924385
First seen Apr 14, 2026 · Last updated May 01, 2026 · Updated 2 times
Summary
This early-stage study tested the safety and how the body handles multiple doses of telpegfilgrastim in 18 non-pregnant women, some of whom had a history of preeclampsia. The goal was to gather safety data and measure drug levels in the blood, not to treat or prevent the condition. Results will help decide if further studies are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University Third Hospital
Beijin, Beijing Municipality, 100191, China
Conditions
Explore the condition pages connected to this study.